DE MATTEIS, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 1.420
EU - Europa 672
AS - Asia 538
SA - Sud America 134
Continente sconosciuto - Info sul continente non disponibili 32
AF - Africa 8
OC - Oceania 1
Totale 2.805
Nazione #
US - Stati Uniti d'America 1.357
IT - Italia 234
SG - Singapore 217
RU - Federazione Russa 152
BR - Brasile 109
CN - Cina 81
DE - Germania 77
VN - Vietnam 65
BD - Bangladesh 57
HK - Hong Kong 56
IE - Irlanda 56
CA - Canada 34
FI - Finlandia 28
GB - Regno Unito 28
IN - India 18
NL - Olanda 18
FR - Francia 16
MX - Messico 13
AT - Austria 12
CZ - Repubblica Ceca 10
ES - Italia 10
AR - Argentina 7
JP - Giappone 7
PL - Polonia 7
SE - Svezia 7
EC - Ecuador 5
UZ - Uzbekistan 5
CO - Colombia 4
IQ - Iraq 4
PH - Filippine 4
TR - Turchia 4
VE - Venezuela 4
ZA - Sudafrica 4
HN - Honduras 3
KZ - Kazakistan 3
RS - Serbia 3
SA - Arabia Saudita 3
UA - Ucraina 3
BE - Belgio 2
CL - Cile 2
GT - Guatemala 2
HU - Ungheria 2
ID - Indonesia 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
PE - Perù 2
PR - Porto Rico 2
RO - Romania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CD - Congo 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GP - Guadalupe 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
SV - El Salvador 1
TN - Tunisia 1
Totale 2.774
Città #
Dallas 417
San Jose 138
Ashburn 123
Singapore 118
Council Bluffs 93
Chandler 55
Dublin 54
Hong Kong 51
Santa Clara 51
New York 41
Munich 33
Los Angeles 32
Boardman 26
Milan 26
Ho Chi Minh City 22
Hanoi 21
The Dalles 21
Rome 18
Moscow 16
Beijing 14
São Paulo 14
Verona 14
Helsinki 11
Kitzingen 11
Naples 11
Lappeenranta 10
Lauterbourg 10
Montreal 10
Toronto 10
Benevento 9
Bologna 8
Brno 8
Falkenstein 8
London 8
Phoenix 8
Atlanta 7
Brooklyn 7
Houston 7
Jacksonville 7
L’Aquila 7
Mexico City 7
Turku 7
Warsaw 7
Hefei 6
Seattle 6
Turin 6
Vienna 6
Chennai 5
Des Moines 5
Frankfurt am Main 5
Lawrence 5
Menlo Park 5
Orem 5
Poplar 5
Princeton 5
Boston 4
Changsha 4
Da Nang 4
Genoa 4
Manchester 4
Mumbai 4
North Bergen 4
Rio de Janeiro 4
Spoltore 4
Stockholm 4
Tashkent 4
Tokyo 4
West Jordan 4
Ankara 3
Bremen 3
Buffalo 3
Cagayan de Oro 3
Catania 3
Charlotte 3
Chicago 3
Curitiba 3
Düsseldorf 3
Florence 3
Haiphong 3
Johannesburg 3
Palermo 3
Pescara 3
Philadelphia 3
Piscataway 3
San Diego 3
San Francisco 3
Shanghai 3
Teramo 3
Venice 3
Waterbury 3
Wilmington 3
Agropoli 2
Amsterdam 2
Annapolis 2
Baltimore 2
Bari 2
Belgrade 2
Birmingham 2
Brussels 2
Bắc Ninh 2
Totale 1.779
Nome #
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 375
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 163
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 143
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 139
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 126
The COVID-19 Pandemic as an Opportunity to Improve Health Care Through a Nurse-Coordinated Multidisciplinary Model in a Headache Specialist Center: The Implementation of a Telemedicine Protocol 125
Role of Estrogens in Menstrual Migraine 123
Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study 120
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 118
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 116
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 114
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives 112
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 108
Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes 108
Acute and Preventive Management of Migraine during Menstruation and Menopause 107
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 107
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 104
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 102
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 91
Menstrually associated migraine 87
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 77
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects? 70
Resistant and refractory migraine: clinical presentation, pathophysiology, and management 63
null 7
Totale 2.805
Categoria #
all - tutte 10.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202257 0 0 0 0 5 0 1 3 8 19 6 15
2022/2023153 8 11 3 15 12 19 0 10 59 1 8 7
2023/202488 6 2 6 3 3 22 1 3 1 9 2 30
2024/2025542 25 10 34 22 48 37 70 38 101 37 73 47
2025/20261.564 62 381 123 165 149 63 134 63 100 156 91 77
2026/2027389 40 48 84 217 0 0 0 0 0 0 0 0
Totale 2.805